Aims and Scope
Pulmonary Pharmacology & Therapeutics is a medical journal published by Elsevier that covers research on the pharmacotherapy of lung diseases. It was established in 1988 as Pulmonary Pharmacology and obtained its current title in 1997.
Key Metrics
5.8
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
78
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.89 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Biochemistry (medical)
SJR
- Q2 Biochemistry (medical)
- Q2 Pharmacology (medical)
- Q2 Medicine (miscellaneous)
- Q2 Pulmonary and Respiratory Medicine
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.84
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
26%
4 to 6 months
58%
7 to 9 months
16%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Lung
- Colchicine
- Prostaglandin
- Lipopolysaccharide
- Pulmonary artery
- Airway inflammation
- Lung cancer
- Inhalation
- Prostaglandin D2
- Spray drying
- Pulmonary hypertension
- Anti-inflammatory
- Mitogen-activated protein kinase
- Cell culture
- Oxidative stress
- Pulmonary fibrosis
- Adult patients
- Airway hyperresponsiveness
- Clinical trial
- Nebulizer
Journal Specifications
| Overview | |
| Publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1988 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Pulmonary Pharmacology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Clinical efficacy of inhaled corticosteroids in equine asthma: a meta-analysis and number needed to treat.
- 1 Mar 25
- Pulmonary pharmacology & therapeutics
-
Full paper
"Lipid Nanoparticles for Pulmonary Fibrosis: A Comprehensive Review".
- 1 Dec 24
- Pulmonary pharmacology & therapeutics
-
Full paper
Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma.
- 1 Dec 24
- Pulmonary Pharmacology & Therapeutics
-
Full paper
Prevalence and clinical significance of pre- and post-bronchodilator airflow obstruction in COPD patients.
- 1 Dec 24
- Pulmonary pharmacology & therapeutics
-
Full paper
ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway
- 1 Dec 24
- Pulmonary Pharmacology & Therapeutics
-
Full paper
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts
- 1 Nov 24
- Pulmonary Pharmacology & Therapeutics
Scite analysis
Powered by scite_
2.2k articles received 37.8k citations see all
- 1,652 Supporting
- 34,829 Mentioning
- 199 Contrasting
Editorial notices
- 2 Retractions
- 9 Withdrawals
- 0 Corrections
- 10 Errata
- 0 Expression of Concern
FAQs
How long has Pulmonary Pharmacology and Therapeutics been actively publishing?
Pulmonary Pharmacology and Therapeutics has been in operation since 1988 till date.
What is the publishing frequency of Pulmonary Pharmacology and Therapeutics ?
Pulmonary Pharmacology and Therapeutics published with a Bi-monthly frequency.
How many articles did Pulmonary Pharmacology and Therapeutics publish last years ?
In 2023, Pulmonary Pharmacology and Therapeutics published 60 articles.
What is the eISSN & pISSN for Pulmonary Pharmacology and Therapeutics ?
For Pulmonary Pharmacology and Therapeutics,eISSN is 1522-9629 and pISSN is1094-5539.
What is Citescore for Pulmonary Pharmacology and Therapeutics ?
Citescore for Pulmonary Pharmacology and Therapeutics is 5.8.
What is H index for Pulmonary Pharmacology and Therapeutics ?
H index for Pulmonary Pharmacology and Therapeutics is 78.
What is SNIP score for Pulmonary Pharmacology and Therapeutics ?
SNIP score for Pulmonary Pharmacology and Therapeutics is 0.84.
What is the SJR for Pulmonary Pharmacology and Therapeutics ?
SJR for Pulmonary Pharmacology and Therapeutics is Q2.
Who is the publisher of Pulmonary Pharmacology and Therapeutics ?
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD is the publisher of Pulmonary Pharmacology and Therapeutics.